Skip to main content

Bladder Cancer News (Page 2)

Related terms: Cancer, Bladder

Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma

PRINCETON, N.J.--(BUSINESS WIRE)-- February 2, 2017 – Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved Opdivo injection, for...

FDA Approves Tecentriq (atezolizumab) for Urothelial Carcinoma

May 18, 2016 – The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cancer

Related drug support groups

methotrexate, Keytruda